Helicobacter pylori infection in pediatric patients

V Tolia1

  • 1Division of Gastroenterology and Nutrition, Children's Hospital of Michigan, 3901 Beaubien Boulevard, Detroit, MI 48201, USA.

Insights

Childhood Helicobacter pylori infection is common and may lead to gastric cancer later in life. This review covers the latest research on H. pylori in children, including its spread, effects, and treatment.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) is a gram-negative bacterium colonizing the gastric mucosa.
  • H. pylori infection in childhood is linked to gastritis and peptic ulcers.
  • Emerging evidence suggests a connection between childhood H. pylori and later gastric cancer risk.

Purpose of the Study:

  • To review recent advancements in understanding H. pylori in children.
  • To address the epidemiology, transmission, and pathophysiology of H. pylori in the pediatric population.
  • To discuss clinical presentation and treatment strategies for H. pylori in children.

Main Methods:

  • Review of recent epidemiologic studies.
  • Analysis of current research on H. pylori transmission routes.
  • Synthesis of data on pathophysiology and clinical manifestations.
  • Evaluation of updated treatment guidelines.

Main Results:

  • H. pylori is prevalent in both symptomatic and asymptomatic children.
  • The natural history and symptom association of H. pylori in children remain debated.
  • Nonulcerative gastritis is a common finding in infected children.

Conclusions:

  • Childhood H. pylori infection warrants further investigation due to potential long-term consequences.
  • Understanding transmission and pathophysiology is crucial for effective management.
  • Standardized diagnostic and treatment approaches are needed for pediatric H. pylori cases.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.